Skip to content
2000
Volume 33, Issue 4
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Specific regions of plasma membrane enriched with cholesterol and sphingolipids, recognized as lipid rafts or membrane rafts, play an essential part in cell signal transduction. The ability to actively utilize or exempt signaling proteins for the reinforcement or inactivation of specific signaling pathways is the prominent characteristic of lipid rafts, enabling them to act as lipid-based units that can affect signal transduction and cell activity. A connection between lipid raft structure changes and enhancement of the mitogen-activated protein kinase (MAPK) pathway has been reported. Moreover, alteration in lipid raft construction in cancer has also been confirmed. Thus, this review aimed to study the relationship between lipid rafts and the MAPK signaling pathway in a variety of cancer types.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673346992250217100052
2025-03-03
2026-02-25

  • From This Site

    /content/journals/cmc/10.2174/0109298673346992250217100052
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. PatraS.K. Dissecting lipid raft facilitated cell signaling pathways in cancer.Biochim. Biophys. Acta20081785218220618166162
     [Google Scholar]
  2. SoteriouC. KalliA.C. ConnellS.D. TylerA.I.I. ThorneJ.L. Advances in understanding and in multi-disciplinary methodology used to assess lipid regulation of signalling cascades from the cancer cell plasma membrane.Prog. Lipid Res.20218110108010.1016/j.plipres.2020.10108033359620
     [Google Scholar]
  3. PikeL.J. HanX. GrossR.W. Epidermal growth factor receptors are localized to lipid rafts that contain a balance of inner and outer leaflet lipids: A shotgun lipidomics study.J. Biol. Chem.200528029267962680410.1074/jbc.M50380520015917253
     [Google Scholar]
  4. IamsW.T. LovlyC.M. Molecular pathways: Clinical applications and future direction of insulin-like growth factor-1 receptor pathway blockade.Clin. Cancer Res.201521194270427710.1158/1078‑0432.CCR‑14‑251826429980
     [Google Scholar]
  5. PollakM. The insulin and insulin-like growth factor receptor family in neoplasia: An update.Nat. Rev. Cancer201212315916910.1038/nrc321522337149
     [Google Scholar]
  6. HuoH. GuoX. HongS. JiangM. LiuX. LiaoK. Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction.J. Biol. Chem.200327813115611156910.1074/jbc.M21178520012538586
     [Google Scholar]
  7. MatthewsL.C. TaggartM.J. WestwoodM. Effect of cholesterol depletion on mitogenesis and survival: The role of caveolar and noncaveolar domains in insulin-like growth factor-mediated cellular function.Endocrinology2005146125463547310.1210/en.2005‑023616166225
     [Google Scholar]
  8. MollinedoF. GajateC. Lipid rafts as signaling hubs in cancer cell survival/death and invasion: Implications in tumor progression and therapy.J. Lipid Res.202061561163510.1194/jlr.TR11900043933715811
     [Google Scholar]
  9. KuckaK. WajantH. Receptor oligomerization and its relevance for signaling by receptors of the tumor necrosis factor receptor superfamily.Front. Cell Dev. Biol.2021861514110.3389/fcell.2020.61514133644033
     [Google Scholar]
  10. Khojasteh PoorF. KeivanM. RamaziiM. GhaedrahmatiF. AnbiyaieeA. PanahandehS. KhoshnamS.E. FarzanehM. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer.Breast Dis.2021402516210.3233/BD‑20106333896802
     [Google Scholar]
  11. DhillonA.S. HaganS. RathO. KolchW. MAP kinase signalling pathways in cancer.Oncogene200726223279329010.1038/sj.onc.121042117496922
     [Google Scholar]
  12. GuoY.J. PanW.W. LiuS.B. ShenZ.F. XuY. HuL.L. ERK/MAPK signalling pathway and tumorigenesis.Exp. Ther. Med.20201931997200732104259
     [Google Scholar]
  13. HommesD.W. PeppelenboschM.P. van DeventerS.J. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.Gut200352114415110.1136/gut.52.1.14412477778
     [Google Scholar]
  14. CastellanoE. SantosE. Functional specificity of ras isoforms: So similar but so different.Genes Cancer20112321623110.1177/194760191140808121779495
     [Google Scholar]
  15. AbankwaD. GorfeA.A. Mechanisms of Ras membrane organization and signaling: Ras rocks again.Biomolecules20201011152210.3390/biom1011152233172116
     [Google Scholar]
  16. ShahS. BrockE.J. JiK. MattinglyR.R. Ras and Rap1: A tale of two GTPases. Seminars in cancer biology.Elsevier2019
     [Google Scholar]
  17. MorrisonD.K. MAP kinase pathways.Cold Spring Harb. Perspect. Biol.2012411a01125410.1101/cshperspect.a01125423125017
     [Google Scholar]
  18. DhanasekaranD.N. ReddyE.P. JNK signaling in apoptosis.Oncogene200827486245625110.1038/onc.2008.30118931691
     [Google Scholar]
  19. JohnsonG.L. LapadatR. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.Science200229856001911191210.1126/science.107268212471242
     [Google Scholar]
  20. MurphyG. NagaseH. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: Destruction or repair?Nat. Clin. Pract. Rheumatol.20084312813510.1038/ncprheum072718253109
     [Google Scholar]
  21. JohnsonG.L. NakamuraK. The c-jun kinase/stress-activated pathway: Regulation, function and role in human disease.Biochim. Biophys. Acta Mol. Cell Res.2007177381341134810.1016/j.bbamcr.2006.12.00917306896
     [Google Scholar]
  22. LiuJ. LinA. Role of JNK activation in apoptosis: A double-edged sword.Cell Res.2005151364210.1038/sj.cr.729026215686625
     [Google Scholar]
  23. YueJ. LópezJ.M. Understanding MAPK signaling pathways in apoptosis.Int. J. Mol. Sci.2020217234610.3390/ijms2107234632231094
     [Google Scholar]
  24. WuQ. WuW. JacevicV. FrancaT.C.C. WangX. KucaK. Selective inhibitors for JNK signalling: A potential targeted therapy in cancer.J. Enzyme Inhib. Med. Chem.202035157458310.1080/14756366.2020.172001331994958
     [Google Scholar]
  25. RoyA. PatraS.K. Lipid raft facilitated receptor organization and signaling: A functional rheostat in embryonic development, stem cell biology and cancer.Stem Cell Rev. Rep.202319122510.1007/s12015‑022‑10448‑335997871
     [Google Scholar]
  26. Barnett-NorrisJ. LynchD. ReggioP.H. Lipids, lipid rafts and caveolae: Their importance for GPCR signaling and their centrality to the endocannabinoid system.Life Sci.200577141625163910.1016/j.lfs.2005.05.04015993425
     [Google Scholar]
  27. DietrichC. BagatolliL.A. VolovykZ.N. ThompsonN.L. LeviM. JacobsonK. GrattonE. Lipid rafts reconstituted in model membranes.Biophys. J.20018031417142810.1016/S0006‑3495(01)76114‑011222302
     [Google Scholar]
  28. NiK. WangC. CarninoJ.M. JinY. The evolving role of caveolin-1: A critical regulator of extracellular vesicles.Med. Sci.2020844610.3390/medsci804004633158117
     [Google Scholar]
  29. AllenJ.A. Halverson-TamboliR.A. RasenickM.M. Lipid raft microdomains and neurotransmitter signalling.Nat. Rev. Neurosci.20078212814010.1038/nrn205917195035
     [Google Scholar]
  30. KabouridisP.S. JuryE.C. Lipid rafts and T-lymphocyte function: Implications for autoimmunity.FEBS Lett.2008582273711371810.1016/j.febslet.2008.10.00618930053
     [Google Scholar]
  31. MastickC.C. SanguinettiA.R. KnesekJ.H. MastickG.S. NewcombL.F. Caveolin-1 and a 29-kDa caveolin-associated protein are phosphorylated on tyrosine in cells expressing a temperature-sensitive v-Abl kinase.Exp. Cell Res.2001266114215410.1006/excr.2001.520511339833
     [Google Scholar]
  32. PradhanB.S. PrószyńskiT.J. A role for caveolin-3 in the pathogenesis of muscular dystrophies.Int. J. Mol. Sci.20202122873610.3390/ijms2122873633228026
     [Google Scholar]
  33. CohenA.W. CombsT.P. SchererP.E. LisantiM.P. Role of caveolin and caveolae in insulin signaling and diabetes.Am. J. Physiol. Endocrinol. Metab.20032856E1151E116010.1152/ajpendo.00324.200314607781
     [Google Scholar]
  34. ZhouM. ShiS.X. LiuN. JiangY. KarimM.S. VodovozS.J. WangX. ZhangB. DumontA.S. Caveolae- mediated endothelial transcytosis across the blood-brain barrier in acute ischemic stroke.J. Clin. Med.20211017379510.3390/jcm1017379534501242
     [Google Scholar]
  35. NadaS. HondoA. KasaiA. KoikeM. SaitoK. UchiyamaY. OkadaM. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK–ERK pathway to late endosomes.EMBO J.200928547748910.1038/emboj.2008.30819177150
     [Google Scholar]
  36. DaumannI.M. HiesingerP.R. Lipid rafts, Rab GTPases, and a late endosomal checkpoint for plasma membrane recycling.Proc. Natl. Acad. Sci. USA202312014e230232012010.1073/pnas.230232012036972457
     [Google Scholar]
  37. BaiZ. GrantB.D. A TOCA/CDC-42/PAR/WAVE functional module required for retrograde endocytic recycling.Proc. Natl. Acad. Sci. USA201511212E1443E145210.1073/pnas.141865111225775511
     [Google Scholar]
  38. DeNiesM.S. Rosselli-MuraiL.K. SchnellS. LiuA.P. Clathrin heavy chain knockdown impacts CXCR4 signaling and post-translational modification.Front. Cell Dev. Biol.201977710.3389/fcell.2019.0007731139626
     [Google Scholar]
  39. LajoieP. NabiI.R. Regulation of raft-dependent endocytosis.J. Cell. Mol. Med.200711464465310.1111/j.1582‑4934.2007.00083.x17760830
     [Google Scholar]
  40. ColinD. LimagneE. JeanningrosS. JacquelA. LizardG. AthiasA. GambertP. HichamiA. LatruffeN. SolaryE. DelmasD. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells.Cancer Prev. Res.2011471095110610.1158/1940‑6207.CAPR‑10‑027421467134
     [Google Scholar]
  41. Le RoyC. WranaJ.L. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling.Nat. Rev. Mol. Cell Biol.20056211212610.1038/nrm157115687999
     [Google Scholar]
  42. BiediC. PanettaD. SegatD. CorderaR. MaggiD. Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae.Endocrinology2003144125497550310.1210/en.2003‑041712960075
     [Google Scholar]
  43. MollinedoF. GajateC. Lipid rafts as major platforms for signaling regulation in cancer.Adv. Biol. Regul.20155713014610.1016/j.jbior.2014.10.00325465296
     [Google Scholar]
  44. WangY. MiaoZ. QinX. YangY. WuS. MiaoQ. LiB. ZhangM. WuP. HanY. LiB. Transcriptomic landscape based on annotated clinical features reveals PLPP2 involvement in lipid raft-mediated proliferation signature of early-stage lung adenocarcinoma.J. Exp. Clin. Cancer Res.202342131510.1186/s13046‑023‑02877‑w37996944
     [Google Scholar]
  45. GreenleeJ.D. SubramanianT. LiuK. KingM.R. Rafting down the metastatic cascade: The role of lipid rafts in cancer metastasis, cell death, and clinical outcomes.Cancer Res.202181151710.1158/0008‑5472.CAN‑20‑219932999001
     [Google Scholar]
  46. TahirS.A. ParkS. ThompsonT.C. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.Cancer Biol. Ther.20098232284229410.4161/cbt.8.23.1013819923922
     [Google Scholar]
  47. ParkM. LimJ.W. KimH. Docoxahexaenoic acid induces apoptosis of pancreatic cancer cells by suppressing activation of STAT3 and NF-κB.Nutrients20181011162110.3390/nu1011162130400136
     [Google Scholar]
  48. ChiangS.K. ChenS.E. ChangL.C. The role of HO-1 and its crosstalk with oxidative stress in cancer cell survival.Cells2021109240110.3390/cells1009240134572050
     [Google Scholar]
  49. PashirzadM. KhorasanianR. FardM.M. ArjmandM.H. LangariH. KhazaeiM. SoleimanpourS. RezayiM. FernsG.A. HassanianS.M. AvanA. The therapeutic potential of MAPK/ERK inhibitors in the treatment of colorectal cancer.Curr. Cancer Drug Targets2021211193294310.2174/156800962166621110311333934732116
     [Google Scholar]
  50. KhanN. AfaqF. SaleemM. AhmadN. MukhtarH. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.Cancer Res.20066652500250510.1158/0008‑5472.CAN‑05‑363616510563
     [Google Scholar]
  51. ZhangZ. WangL. DuJ. LiY. YangH. LiC. LiH. HuH. Lipid raft localization of epidermal growth factor receptor alters matrix metalloproteinase-1 expression in SiHa cells via the MAPK/ERK signaling pathway.Oncol. Lett.20161264991499810.3892/ol.2016.530728101233
     [Google Scholar]
  52. ZuoW. ChenY.G. Specific activation of mitogen-activated protein kinase by transforming growth factor-β receptors in lipid rafts is required for epithelial cell plasticity.Mol. Biol. Cell20092031020102910.1091/mbc.e08‑09‑089819056678
     [Google Scholar]
  53. SunY.S. ZhaoZ. YangZ.N. XuF. LuH.J. ZhuZ.Y. ShiW. JiangJ. YaoP.P. ZhuH.P. Risk factors and preventions of breast cancer.Int. J. Biol. Sci.201713111387139710.7150/ijbs.2163529209143
     [Google Scholar]
  54. KwonM.J. Matrix metalloproteinases as therapeutic targets in breast cancer.Front. Oncol.202312110869510.3389/fonc.2022.110869536741729
     [Google Scholar]
  55. RaghuH. SodadasuP.K. MallaR.R. GondiC.S. EstesN. RaoJ.S. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.BMC Cancer201010164710.1186/1471‑2407‑10‑64721106094
     [Google Scholar]
  56. YamaguchiH. TakeoY. YoshidaS. KouchiZ. NakamuraY. FukamiK. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.Cancer Res.200969228594860210.1158/0008‑5472.CAN‑09‑230519887621
     [Google Scholar]
  57. LuP. TakaiK. WeaverV.M. WerbZ. Extracellular matrix degradation and remodeling in development and disease.Cold Spring Harb. Perspect. Biol.2011312a00505810.1101/cshperspect.a00505821917992
     [Google Scholar]
  58. Abdel-HamidN.M. AbassS.A. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.Mol. Biol. Rep.20214896525653810.1007/s11033‑021‑06635‑z34379286
     [Google Scholar]
  59. WolczykD. Zaremba-CzogallaM. Hryniewicz-JankowskaA. TabolaR. GrabowskiK. SikorskiA.F. AugoffK. TNF-α promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts.Cell Oncol.201639435336310.1007/s13402‑016‑0280‑x27042827
     [Google Scholar]
  60. LabiancaR. BerettaG.D. KildaniB. MilesiL. MerlinF. MosconiS. PessiM.A. ProchiloT. QuadriA. GattaG. de BraudF. WilsJ. Colon cancer.Crit. Rev. Oncol. Hematol.201074210613310.1016/j.critrevonc.2010.01.01020138539
     [Google Scholar]
  61. YeD.M. YeS.C. YuS.Q. ShuF.F. XuS.S. ChenQ.Q. WangY.L. TangZ.T. PanC. Drug-resistance reversal in colorectal cancer cells by destruction of flotillins, the key lipid rafts proteins.Neoplasma201966457658310.4149/neo_2018_180820N63330943747
     [Google Scholar]
  62. ZhuW. LiM.C. WangF.R. MackenzieG.G. OteizaP.I. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.Biochem. Pharmacol.202017511392310.1016/j.bcp.2020.11392332217102
     [Google Scholar]
  63. YoonY.J. KimD.K. YoonC.M. ParkJ. KimY.K. RohT.Y. GhoY.S. EGR-1 activation by cancer-derived extracellular vesicles promotes endothelial cell migration via ERK1/2 and JNK signaling pathways.PLoS One2014912e11517010.1371/journal.pone.011517025502753
     [Google Scholar]
  64. CascinuS. FalconiM. ValentiniV. JelicS. Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann. Oncol.201021Suppl. 5v55v5810.1093/annonc/mdq16520555103
     [Google Scholar]
  65. SiegelR MillerK JemalA. Cancer Statistics, 2017.CA Cancer J Clin.2017671730
     [Google Scholar]
  66. ShiH. FangW. LiuM. FuD. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.Int. J. Cancer201714171389140110.1002/ijc.3083128608366
     [Google Scholar]
  67. XuR. SongJ. RuzeR. ChenY. YinX. WangC. ZhaoY. SQLE promotes pancreatic cancer growth by attenuating ER stress and activating lipid rafts-regulated Src/PI3K/Akt signaling pathway.Cell Death Dis.202314849710.1038/s41419‑023‑05987‑737542052
     [Google Scholar]
  68. JinH. KohM. LimH. YongH.Y. KimE.S. KimS.Y. KimK. JungJ. RyuW.J. ChoiK.Y. MoonA. Lipid raft protein flotillin-1 is important for the interaction between SOS1 and H-Ras/K-Ras, leading to Ras activation.Int. J. Cancer202315291933194610.1002/ijc.3444336691829
     [Google Scholar]
  69. LitwinM.S. TanH.J. The diagnosis and treatment of prostate cancer: A review.JAMA2017317242532254210.1001/jama.2017.724828655021
     [Google Scholar]
  70. ŠkaraL. Huđek TurkovićA. PezeljI. VrtarićA. SinčićN. KrušlinB. UlamecM. Prostate cancer—Focus on cholesterol.Cancers 20211318469610.3390/cancers1318469634572923
     [Google Scholar]
  71. AldahlJ. MiJ. PinedaA. KimW.K. OlsonA. HookerE. HeY. YuE.J. LeV. LeeD.H. GeradtsJ. SunZ. Aberrant activation of hepatocyte growth factor/MET signaling promotes β-catenin–mediated prostatic tumorigenesis.J. Biol. Chem.2020295263164410.1074/jbc.RA119.01113731819003
     [Google Scholar]
  72. ComoglioP.M. GiordanoS. TrusolinoL. Drug development of MET inhibitors: Targeting oncogene addiction and expedience.Nat. Rev. Drug Discov.20087650451610.1038/nrd253018511928
     [Google Scholar]
  73. DuhonD. BigelowR.L.H. ColemanD.T. SteffanJ.J. YuC. LangstonW. KevilC.G. CardelliJ.A. The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells.Mol. Carcinog.201049873974910.1002/mc.2064920623641
     [Google Scholar]
  74. ChinniS.R. SivaloganS. DongZ. FilhoJ.C.T. DengX. BonfilR.D. CherM.L. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: The role of bone microenvironment-associated CXCL12.Prostate2006661324810.1002/pros.2031816114056
     [Google Scholar]
  75. ChinniS.R. YamamotoH. DongZ. SabbotaA. BonfilR.D. CherM.L. CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone.Mol. Cancer Res.20086344645710.1158/1541‑7786.MCR‑07‑011718337451
     [Google Scholar]
  76. KukrejaP. Abdel-MageedA.B. MondalD. LiuK. AgrawalK.C. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1α (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.Cancer Res.200565219891989810.1158/0008‑5472.CAN‑05‑129316267013
     [Google Scholar]
  77. ChenJ. QinP. TaoZ. DingW. YaoY. XuW. YinD. TanS. Anticancer activity of methyl protodioscin against prostate cancer by modulation of cholesterol-associated MAPK signaling pathway via FOXO1 induction.Biol. Pharm. Bull.202346457458510.1248/bpb.b22‑0068237005301
     [Google Scholar]
  78. OhH.Y. LeeE.J. YoonS. ChungB.H. ChoK.S. HongS.J. Cholesterol level of lipid raft microdomains regulates apoptotic cell death in prostate cancer cells through EGFR-mediated Akt and ERK signal transduction.Prostate200767101061106910.1002/pros.2059317469127
     [Google Scholar]
  79. Abbasi-TajaragK. DivsalarA. SabouryA.A. GhalandariB. GhourchianH. Destructive effect of anticancer oxali-palladium on heme degradation through the generation of endogenous hydrogen peroxide.J. Biomol. Struct. Dyn.201634112493250410.1080/07391102.2015.112140826651835
     [Google Scholar]
  80. VaidyaF.U. Sufiyan ChhipaA. MishraV. GuptaV.K. RawatS.G. KumarA. PathakC. Molecular and cellular paradigms of multidrug resistance in cancer.Cancer Rep.2022512e129110.1002/cnr2.129133052041
     [Google Scholar]
  81. KarthikaC. SureshkumarR. ZehraviM. AkterR. AliF. RamproshadS. MondalB. TagdeP. AhmedZ. KhanF.S. RahmanM.H. CavaluS. Multidrug resistance of cancer cells and the vital role of P-glycoprotein.Life 202212689710.3390/life1206089735743927
     [Google Scholar]
  82. KawanoT. InokuchiJ. EtoM. MurataM. KangJ.H. Activators and inhibitors of protein kinase C (PKC): Their applications in clinical trials.Pharmaceutics20211311174810.3390/pharmaceutics1311174834834162
     [Google Scholar]
  83. QinJ. YeL. WenX. ZhangX. DiY. ChenZ. WangZ. Fatty acids in cancer chemoresistance.Cancer Lett.202357221635210.1016/j.canlet.2023.21635237597652
     [Google Scholar]
  84. KopeckaJ. TrouillasP. GašparovićA.Č. GazzanoE. AssarafY.G. RigantiC. Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets.Drug Resist. Updat.20204910067010.1016/j.drup.2019.10067031846838
     [Google Scholar]
  85. ZengY. ZhangX. LinD. FengX. LiuY. FangZ. ZhangW. ChenY. ZhaoM. WuJ. JiangL. A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia.J. Hematol. Oncol.202114118910.1186/s13045‑021‑01199‑834749790
     [Google Scholar]
  86. MukerjeeS. SaeedanA.S. AnsariM.N. SinghM. Polyunsaturated fatty acids mediated regulation of membrane biochemistry and tumor cell membrane integrity.Membranes 202111747910.3390/membranes1107047934203433
     [Google Scholar]
  87. KaiserF. HuebeckerM. WachtenD. Sphingolipids controlling ciliary and microvillar function.FEBS Lett.2020594223652366710.1002/1873‑3468.1381632415987
     [Google Scholar]
  88. YanA. JiaZ. QiaoC. WangM. DingX. Cholesterol metabolism in drug-resistant cancer (Review).Int. J. Oncol.20205751103111533491740
     [Google Scholar]
  89. GuptaV.K. SharmaN.S. KeshK. DauerP. NomuraA. GiriB. DudejaV. BanerjeeS. BhattacharyaS. SalujaA. BanerjeeS. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity.Cancer Lett.201843910111210.1016/j.canlet.2018.09.02830290209
     [Google Scholar]
  90. ShenH. XuW. LuoW. ZhouL. YongW. ChenF. WuC. ChenQ. HanX. Upregulation of MDR1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma.Exp. Hematol.201139555856910.1016/j.exphem.2011.01.01321300134
     [Google Scholar]
  91. LianW.J. LiuG. LiuY.J. ZhaoZ.W. YiT. ZhouH.Y. Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.Oncol. Rep.201330119320010.3892/or.2013.246223674072
     [Google Scholar]
  92. ChenS. WangY. RuanW. WangX. PanC. Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity.Oncol. Lett.2014852333233910.3892/ol.2014.252125295120
     [Google Scholar]
  93. WeiJ. WangR. LuY. HeS. DingY. Flotillin-1 promotes progression and dampens chemosensitivity to cisplatin in gastric cancer via ERK and AKT signaling pathways.Eur. J. Pharmacol.202291617463110.1016/j.ejphar.2021.17463134774850
     [Google Scholar]
  94. GajateC. Gonzalez-CamachoF. MollinedoF. Lipid raft connection between extrinsic and intrinsic apoptotic pathways.Biochem. Biophys. Res. Commun.2009380478078410.1016/j.bbrc.2009.01.14719338752
     [Google Scholar]
  95. GniadeckiR. Depletion of membrane cholesterol causes ligand-independent activation of Fas and apoptosis.Biochem. Biophys. Res. Commun.2004320116516910.1016/j.bbrc.2004.05.14515207716
     [Google Scholar]
  96. MiyajiM. JinZ.X. YamaokaS. AmakawaR. FukuharaS. SatoS.B. KobayashiT. DomaeN. MimoriT. BloomE.T. OkazakiT. UmeharaH. Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis.J. Exp. Med.2005202224925910.1084/jem.2004168516009715
     [Google Scholar]
  97. IwaiK. KondoT. WatanabeM. YabuT. KitanoT. TaguchiY. UmeharaH. TakahashiA. UchiyamaT. OkazakiT. Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis.J. Biol. Chem.2003278119813982210.1074/jbc.M20186720012511568
     [Google Scholar]
  98. GiladL.A. BreslerT. GnainskyJ. SmirnoffP. SchwartzB. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.J. Endocrinol.2005185357759210.1677/joe.1.0577015930183
     [Google Scholar]
  99. HinoM. DoiharaH. KobayashiK. AoeM. ShimizuN. Caveolin-1 as tumor suppressor gene in breast cancer.Surg. Today200333748649010.1007/s10595‑002‑2538‑414506991
     [Google Scholar]
  100. PatlollaJ. SwamyM. RajuJ. RaoC. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines.Oncol. Rep.200411595796310.3892/or.11.5.95715069532
     [Google Scholar]
  101. SarnataroD. GrimaldiC. PisantiS. GazzerroP. LaezzaC. ZurzoloC. BifulcoM. Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells.FEBS Lett.2005579286343634910.1016/j.febslet.2005.10.01616263116
     [Google Scholar]
  102. TamashiroP.M. FuruyaH. ShimizuY. KawamoriT. Sphingosine kinase 1 mediates head & neck squamous cell carcinoma invasion through sphingosine 1-phosphate receptor 1.Cancer Cell Int.20141417610.1186/s12935‑014‑0076‑x25197261
     [Google Scholar]
/content/journals/cmc/10.2174/0109298673346992250217100052
Loading
The Role of Lipid Rafts in the Mitogen-Activated Protein Kinase Signaling in Cancer
Curr. Med. Chem. 33, 726 (2026); https://doi.org/10.2174/0109298673346992250217100052
/content/journals/cmc/10.2174/0109298673346992250217100052
/content/journals/cmc/10.2174/0109298673346992250217100052
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): chemoresistance; ERK1/2; Lipid rafts; MAPK; signal transduction; tumor

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test